Account Info
Log Out
English
Back
Log in to access Online Inquiry
Back to the Top
Weight-loss drugmaker surpasses LVMH: What's your thought?
Event Description
Ended
Have you ever heard of Wegovy, a weight-loss prescription medication? Last Friday, the market value of its Danish parent company, Novo Nordi Show More
Have you ever heard of Wegovy, a weight-loss prescription medication? Last Friday, the market value of its Danish parent company, Novo Nordisk, surpassed luxury giant LVMH, becoming Europe's most valuable listed company.

Something more to know:
First launched in the US market in June 2021, Wegovy has quickly become a globally hot-selling drug in short supply, with even Elon Musk's recommendation. Recently, Novo Nordisk has announced that this drug will be available in the UK from September 4 at a monthly price as low as approximately 19% of the price in the US. It is also worth mentioning that the US shares of Novo Nordisk have risen by more than 40% this year, and the pharmaceutical giant Lilly has also gained by more than 50% in stock price, both setting new record highs.

Q:
· Are you optimistic about the weight loss drug market? What investment opportunities are there?
· You are also welcome to share your experiences and feelings in weight-loss medicine, if any.
Views
24K
Posts
17
Join event
Latest
Hot
Related Stocks
  • NVO
    Novo-Nordisk A/S
    110.770
    +1.79%
  • LLY
    Eli Lilly and Co
    826.710
    +0.13%
  • VKTX
    Viking Therapeutics
    50.800
    +1.84%